Observational Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Aug 7, 2021; 27(29): 4913-4928
Published online Aug 7, 2021. doi: 10.3748/wjg.v27.i29.4913
Table 1 Clinical characteristics according to non-alcoholic fatty liver disease-associated steatosis severity

Mild (n = 182)
Moderate/severe (n = 123)
P value1
Age (yr)50 (44-54)52 (45-57)0.002
Gender
Male99 (54)72 (59)0.503
Female83 (46)51 (41)
Race
Black17 (9)15 (12)0.383
Brown52 (29)41 (34)
White109 (61)61 (50)
Asian2 (1)3 (2)
Indigenous0 (0)2 (2)
Use of alcohol
Never used15 (8)10 (8)0.144
Ex-user46 (25)22 (18)
User121 (67)91 (74)
Smoking habit
Non smoker102 (56)62 (50)0.261
Smoker80 (44)61 (50)
Metabolic syndrome (NCEP ATP III)
Presence62 (34)78 (63)< 0.001
Absence120 (66)45 (37)
Diabetes mellitus
Presence25 (14)45 (37)< 0.001
Absence157 (86)78 (63)
High cholesterol
Presence59 (33)62 (51)< 0.001
Absence122 (67)61 (49)
Body mass index (kg/m2)26.6 (24.6-29.6)29.2 (27.2-32.3)< 0.001
Waist circumference (cm)94.1 (87.5-100.0)101.5 (94.1-107.5)< 0.001
Systolic blood pressure (mmHg)117 (108-127.5)121.5 (113.5-131.2)0.001
Diastolic blood pressure (mmHg)75.5 (69.6-81.5)79.5 (74.0-86.0)< 0.001
Laboratory
Fasting glucose (mg/dL)99.28 (93.33-105.84)104.24 (97.79-116.14)< 0.001
HbA1c (mg/dL)5.40 (5.1-5.8)5.76 (5.3-6.2)< 0.001
Insulin (mcUI/mL)9.91 (7.1-13.9)13.71 (10.5-19.32)< 0.001
Total cholesterol (mg/dL)199.6 (176.8-227.6)196.2 (175.3-222.8)0.636
Triglycerides (mg/dL)107.8 (79.0-152.4)137.15 (99.6-225.0)< 0.001
HDL (mg/dL)50.1 (42.9-60.1)47.45 (42.0-54.2)0.007
ALT (mg/dL)25 (19-33)30 (22.5-40)0.001
AST (mg/dL)24 (21-28)24 (21-29.5)0.276
GGT (mg/dL)24 (18-35)33 (23-51)< 0.001
hs-CRP (mg/dL)1.6 (0.8-3.5)2.2 (1.4-4.7)< 0.001
Uric acid (mg/dL)5.4 (4.5-6.6)6 (5.2-6.9)< 0.001
Microalbuminuria (mg/dL)0.50 (0.33-0.82)0.51 (0.31-1.05)0.265
Creatinine (mg/dL)0.87 (0.77-0.97)0.87 (0.77-0.97)0.324
Sodium (mg/dL)143 (141-144)143 (141-144)0.200
Potassium (mg/dL)4.5 (4.2-4.7)4.4 (4.2-4.7)0.820